Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Personalized Ultrasonic Brain Stimulation for Depression (R61)

NCT: NCT06902298 · RECRUITING

NCT IDNCT06902298
StatusRECRUITING
Start Date2025-03-10
Completion2026-11

Brief Summary

This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will be delivered using a range of stimulation parameters during psychological and physiological monitoring. Individualized optimal targets will be selected using structural MRI and diffusion tractography. Brain target engagement will be evaluated using functional MRI.

Frequently Asked Questions

What is Personalized Ultrasonic Brain Stimulation for Depression (R61)?

Personalized Ultrasonic Brain Stimulation for Depression (R61) is a clinical trial registered under NCT06902298. Current status: RECRUITING.

What is the status of NCT06902298?

The current status of NCT06902298 (Personalized Ultrasonic Brain Stimulation for Depression (R61)) is: RECRUITING.

When did Personalized Ultrasonic Brain Stimulation for Depression (R61) start?

Personalized Ultrasonic Brain Stimulation for Depression (R61) started on 2025-03-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑